Compare early pregnancy blood-flow markers in preeclampsia
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at blood-flow and artery health signs during pregnancy to better understand why preeclampsia happens. It compares women with preeclampsia to women with an uncomplicated pregnancy, and may help improve early detection and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older.
- You are either currently pregnant with preeclampsia, or currently have a pregnancy without major placental or mother complications.
- If you join, you must be willing to learn your test results and allow your general doctor and specialists to be informed.
- You cannot be allergic to nitroglycerin (glyceryl trinitrate), beta-blockers, or iodine-based contrast dye.
- If you are in the control group, you cannot have chronic high blood pressure needing medication or an autoimmune condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures blood vessel–related markers in pregnant people who already have high blood pressure or early preeclampsia. The goal is to predict who is more likely to get worse, so care can be better targeted.
This study is testing a new blood test that might help doctors quickly and safely identify preeclampsia, a serious pregnancy condition. If you're at risk, this test could help you get the right care earlier.
This study looks at how the placenta and blood vessels work in pregnancy, especially in preeclampsia and babies with growth restriction (IUGR). It may help researchers build a blood sample collection and learn what could predict or explain these complications.
This study tests a finger sensor to see if it can help doctors decide when pregnant women with severe preeclampsia need more fluids. It compares results from healthy pregnant women and those with severe preeclampsia.
This pilot study looks at tiny particles in blood (microvesicles) to learn how they differ in women with threatened preterm delivery, with or without pre-eclampsia. Results may help doctors better identify risk and improve care for early delivery.
This trial is looking for women with preeclampsia to help find markers in the blood that show how blood vessels are affected. The goal is to better understand the condition and possibly improve future care.
Hear when a new Pre-Eclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.